bioMérieux

Accelix is a biotechnology company that helps cell and gene therapy companies to meet their key product QC requirements. It provides an instrument and a room temperature stable cartridge to gather multi-parameter results. The company was founded in 2007 and headquartered in Yerushalayim, Israel.

At Invisible Sentinel, we develop first in class, next generation technologies for a safer food supply. As innovators in rapid diagnostics, we focus on the prevention of foodborne illnesses by developing leading-edge molecular and antigen detection technologies that quickly provide highly accurate information on the presence of harmful pathogens reducing time-consuming sample preparation. Uniquely designed for easy, practical use—on-site and throughout the entire food distribution network—our patented and AOAC approved Veriflow™ technology promises to create a new standard for rigorous quality control.

SuZhou Hybiome Biomedical Engineering engages in research, manufacturing, and sales of instruments and matching reagents for clinical immunological analysis and blood tests.

Astute Medical is dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. The Company's focus is on community and hospital-acquired acute conditions that require rapid diagnosis and risk assessment. The company's current areas of interest include abdominal pain, acute coronary syndromes, cerebrovascular injury, kidney injury and sepsis. Founded in 2007, the company is led by Christopher Hibberd and Paul McPherson, former members of the management at Biosite Incorporated, a leading diagnostics company acquired by Inverness Medical Innovations in 2007 for $1.7 billion. Hibberd served at Biosite for 10 years, most recently as Senior Vice President Corporate Development. Dr. McPherson was at Biosite for 14 years, most recently as Vice President Research and Development.

Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the primary goal of dramatically reducing time to results in microbiology. This objective, widely recognized as highly desirable, has proved elusive yet holds the promise of revolutionizing how medicine is practiced by offering actionable results in clinically relevant time frames to improve patient outcomes and save lives. Qvella's Field Activated Sample Treatment (FAST™) technology utilizes a novel electrical lysing and sample treatment technique we call e-lysis™; enabling direct and fully-automated rapid detection of infectious agents from unenriched biological samples.

As an established Biotech company, Hyglos is dedicated to exploit the biochemical principles evolved by bacteriophages for healthcare applications. The abundance of bacteriophages in nature and the unmet precision in occupying and destroying their host bacteria provide an almost unlimited pool for target-specific protein tools.

Applied Maths develops professional bioinformatics applications and services with emphasis on data integration, platform technology and networking.

SARL ADVENCIS is a privately held company that manufactures lab instruments and medical devices.

BioFire Diagnostics is a privately held clinical diagnostics company based in Salt Lake City, Utah. Founded in 1990, the Company currently holds over 70 patents related to polymerase chain reaction (PCR), including rapid PCR cycling. The Company has used its extensive patent portfolio to successfully market nearly 200 products to the clinical, research and military markets.

Quanterix Corporation is developing a novel platform for single-molecule analysis that will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research. Their unique approach permits rapid quantification and analysis of individual proteins and small molecules within complex biological samples, enabling us to address a variety of unmet medical needs. The company’s ultra-sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterix’s technology is designed to enable much earlier disease detection, better prognosis, and precise treatment methods to improve the quality of life and longevity of the population for generations to come.

RAS Lifesciences mainly focused on Molecular biology based product development and manufacturing.

RTS Life Sciences Ltd. manufactures and provides automated products and solutions for industrial and scientific applications.

Argene SA is a specialising in molecular diagnostics for immunocompromised patients.

AES Laboratoire has products spanning applications for the food, pharmaceutical, and cosmetic industries. The company’s offerings include a complete portfolio of conventional and novel culture media, rapid microbiology testing methods, and laboratory instruments, as well as cytometry for the detection of microorganisms, with an innovative range of flow cytometers and a solid-phase cytometer, ChemScan RDI. The company also provides a range of services, as well as software for laboratory monitoring and metrology.

Shanghai Zenka Biotechnology is a biotechnology company.

Meikang Biotech is acompany has a wide range of rapid tests based on lateral flow immunoassay technology, including tests for infectious diseases, cardiovascular diseases and cancer. Many of these products are CE marked and some have received FDA 510k approval.

PML Microbiologicals, Inc. manufactures culture media and microbiological products for clinical and industrial applications in North America. It offers prepared culture media, stains, reagents, quality control organisms, sterility products, and collection and transport systems, as well as accessories for microbiology laboratories. The company also provides custom products, such as minimum inhibitory concentration panels, parasitology kits, diluents, and rinsing fluids. It serves clinical, pharmaceutical, research, environmental, personal care, and food and beverage industries. PML Microbiologicals, Inc. was formerly known as Prepared Media Laboratory. The company was founded in 1969 and is headquartered in Wilsonville, Oregon. It has manufacturing facilities in Mississauga, Canada; and Portland, Oregon. As of December 8, 2008, PML Microbiologicals, Inc. operates as a subsidiary of BioMérieux S.A.

AviaraDx discovers, develops, and commercializes new molecular diagnostic tests in oncology, enabling physicians to personalize cancer treatment through better understanding of the molecular biology underlying a patient’s tumor. Our tests improve the classification of cancer, support physicians to provide their patients with a more specific prognosis or individual risk assessment, and will eventually provide information critical to predict treatment response to a given therapeutic regimen. AviaraDx offers diagnostic tests to qualified physicians or laboratories through its certified CLIA and CAP laboratory service operations. The company's first two diagnostic test offerings are based on its proprietary technologies used in molecular classification of metastatic cancer (CancerTYPE ID™) and its test to assess risk of recurrence in certain breast cancer patients, (H/I™ (HOXB13/IL17BR).

AB bioMérieux is a privately held company that designs, develops, produces, and markets diagnosis systems for medical applications.

AdvanDx is a leading provider of rapid and accurate molecular diagnostic tests for the identification of pathogens causing critical infections in hospitalized patients. Its mission is to help healthcare providers optimize antibiotic therapy earlier in order to improve patient outcomes while limiting unnecessary antibiotic use and reducing hospital costs. AdvanDx was founded in 2002 and headquartered in Woburn, Massachusetts.

BTF Pty is a manufacturer and supplier of the world’s most precise quality controls for Cryptosporidium and Giardia testing, helping to deliver safe drinking water.

Biomedics is a specialized technical laboratory in elaboration of prepared culture and diagnostic media.

Bacterial Barcodes provides the equipment, reagents and software for microbial genotyping of bacteria and fungi. Packaged together, these components are referred to as the DiversiLab System.

Since 2017, MEDoctor's mission is to empower the patient to help himself determine his health problems and thereby to be routed towards the appropriate healthcare professional. The MEDoctor artificial intelligence based health assessment system won’t replace a medical visit to the doctor to have the final diagnosis and the correct treatment. But it will be useful to identify which pain, disease or illness can correspond to the symptoms you have and then make the choice of the physician to see or the treatment to follow. The MEDoctor Symptom Checker is a guide that will help you for all kinds of problems, for a benign disease as a cold or something more serious as a cancer. MEDoctor is one of the world’s most advanced symptom checkers, with its artificial intelligence and the patents to protect it. Diseases we can detect include back pain, knee pain, breast cancer, diabetes, skin cancer, heart disease, liver disease, depression, body aches, diarrhea, kidney infection, asthma, lymphoma. The list of possible disease covered is now close to 1'000. The MEDoctor Symptom Checker Version 4.1 is available “Free-of-Cost” to individuals worldwide. Individuals, family members and friends may use it as often as necessary and wherever the Internet is accessible. The system is user-friendly and works on any web-enabled device. Prior to 2017, MEDoctor had worked on and developed patient enrollment systems, such as registration at the HMO, delivery of basic health symptoms and populating of electronic health records. These systems, essentially mainframe computer based, were targeting hospitals, HMOs and IPAs and with the assistance of a healthcare professional. Since 2014, MEDoctor has taken a different route by progressively building upon its legacy systems a brand new technology, capable of running on the Cloud and suited for the patient on his smartphone. Thereafter, when the patient decides to speak to a physician, he can immediately deliver his accumulated data, symptoms and likely diseases, to facilitate the physicians diagnosis.